• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN PROTEGE EVERFLX; STENT, SUPERFICIAL FEMORAL ARTERY,

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN PROTEGE EVERFLX; STENT, SUPERFICIAL FEMORAL ARTERY, Back to Search Results
Model Number PRB35-07100120V05
Device Problem Component Missing (2306)
Patient Problem Device Embedded In Tissue or Plaque (3165)
Event Date 09/18/2014
Event Type  Injury  
Event Description
The protege everflex was delivered through a 90cm sheath.When sheath was advanced stent started to deploy.When the undeployed stent and stent delivery system were removed it was noticed that part of the stent was missing.A piece of protege everflex stent was located in the external iliac.After ballooning the piece it was decided to stent it.A balloon expandable stent was deployed with a great result.Flow was good post procedure.
 
Manufacturer Narrative
A review of the manufacture records for this device did not reveal any discrepancies relevant to the reported event.
 
Manufacturer Narrative
This supplemental mdr is being submitted as a part of a retrospective review / remediation effort performed at the covidien (b)(4) location, following medtronic¿s acquisition of covidien.A capa has been opened to manage the actions related to remediation of complaint files and any required mdr reporting.
 
Event Description
Evaluation summary: the protege everflex stent delivery system (sds) was received for evaluation without any ancillary devices or cine images from the procedure.The stent was partially deployed and torn on the distal edge.The manifold assembly lock-mechanism was tight (locked) and was fully functional.The inner shaft hypotube was held securely when the thumbscrew was tightened but would move easily when the thumbscrew was loosened.The stent tear was irregular but the fracture (tear) sites were consistently at the edge of a hairpin bend.The deployment paddles were brought together and the remainder of the stent deployed easily.The retainer was appropriately positioned at full-deploy.The stent length was between 19.5 cells and 20.5 cells.The design for this stent calls for a cell length of 21 cells.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROTEGE EVERFLX
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY,
Manufacturer (Section D)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
Manufacturer Contact
stephanie riley
4600 nathan lane north
plymouth, MN 55442
7633987000
MDR Report Key4168647
MDR Text Key5088615
Report Number2183870-2014-00257
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P110023
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility,Company Representative,company representati
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 09/18/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/14/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/03/2017
Device Model NumberPRB35-07100120V05
Device Catalogue NumberPRB35-07100120V05
Device Lot Number9863972
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/29/2014
Is the Reporter a Health Professional? No
Date Manufacturer Received09/18/2014
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured02/04/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age76 YR
Patient Weight76
-
-